STEPHANIE SLACK: Open Payments
NPI 1619417268 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 48 payments from 19 companies in 2025. Trend: 2023 $1,439 · 2024 $1,267 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $147 |
| Antares Pharma, Inc. | 7 | $103 |
| PFIZER INC. | 5 | $84 |
| Corcept Therapeutics | 2 | $74 |
| Abbott Laboratories | 3 | $63 |
| ABBVIE INC. | 3 | $47 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Lilly USA, LLC | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $34 |
Products named: Wegovy, XYOSTED, Korlym, FREESTYLE LIBRE 3, UBRELVY, NURTEC ODT, MOUNJARO, ELIQUIS.
Industry payments across TX — which companies pay providers there.
